Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q79673143)
Watch
English
Fabry's disease
scientific article published on 01 October 2008
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Fabry's disease
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
main subject
Fabry disease
1 reference
based on heuristic
inferred from title
author
Yuri A Zarate
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
Robert J. Hopkin
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
language of work or name
English
0 references
publication date
1 October 2008
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
volume
372
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
issue
9647
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
page(s)
1427-1435
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
cites work
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High incidence of later-onset fabry disease revealed by newborn screening
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiac involvement in Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The heart in Anderson-Fabry disease and other lysosomal storage disorders.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results of a nationwide screening for Anderson-Fabry disease among dialysis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Narrative review: Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alpha-galactosidase A in vascular disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CNS pathology and vascular/circulatory abnormalities in Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The cerebral vasculopathy of Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Staging of Fabry disease using renal biopsies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis and management of kidney involvement in Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative evaluation of alpha-galactosidase A infusions for treatment of Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disease manifestations and X inactivation in heterozygous females with Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Manifestations of Fabry disease in placental tissue
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of Fabry disease in females in the Fabry Outcome Survey.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quality of life of patients with Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry disease in childhood
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical benefit of enzyme replacement therapy in Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry disease: overall effects of agalsidase alfa treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme replacement in Fabry disease: the essence is in the kidney
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry disease: guidelines for the evaluation and management of multi-organ system involvement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early Detection of Fabry Cardiomyopathy by Tissue Doppler Imaging
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Images in cardiovascular medicine. Cryptogenic ventricular arrhythmias and sudden death by Fabry disease: prominent infiltration of cardiac conduction tissue
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence of uncontrolled hypertension in patients with Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular manifestations of Fabry disease and the novel therapeutic strategies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neurology of Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CNS manifestations of Fabry's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Magnetic resonance imaging changes in Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hearing loss in Fabry disease: data from the Fabry Outcome Survey.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polyneuropathies in teenagers: a clinicopathological study of 45 cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry disease and the skin: data from FOS, the Fabry outcome survey.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pediatric Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High incidence of thrombosis in Fabry's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endocrine dysfunction in patients with Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative dysmorphology assessment in Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agalsidase Beta: a review of its use in the management of Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme replacement therapy in Fabry disease: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme replacement therapy with agalsidase alfa in children with Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical benefit in Fabry patients given enzyme replacement therapy--a case series
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary manifestations of Fabry disease and positive response to enzyme replacement therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of antibody formation on reduction of globotriaosylceramide (GL-3) in urine from Fabry patients during agalsidase beta therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Screening for pharmacological chaperones in Fabry disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961589-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(08)61589-5
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
PubMed ID
18940466
1 reference
stated in
Europe PubMed Central
PubMed ID
18940466
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18940466%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit